H2U, a leading digital health brand based in Taiwan, recently announced exciting news as it welcomed strategic investment partners, including Seoul Clinical Laboratories (SCL), Standard Foods, Leadgene Biomedical, and GrandTech C.G. Systems, raising over 10 million USD in a successful Series B fundraising round. This substantial funding will bolster H2U’s research and development efforts, AI data insights, and product promotion, allowing them to enhance their holistic health solutions for thousands of domestic companies.
With over 3,000,000 platform members and a decade of experience, H2U integrates various services such as H2U eXpert, H2U eXamine, Everyday Health, Sports Note, and iFit to provide personalized health plans tailored to individual needs. Through their flagship product, H2U cloth, members can access top-quality medical examination structures and personalized testing solutions, guiding them through a comprehensive digital health journey.
The company’s core focus on Lifestyle Medicine has attracted nearly 500 organizations to become members of H2U cloth, enabling them to benefit from AI-driven health risk assessments, personalized health plans, and a variety of health-related resources. Partnering with industry leaders, H2U aims to revolutionize digital health in Taiwan and beyond by leveraging cloud technology to enhance their AI engine’s data insight analysis and expand their range of health solutions.
In 2024, H2U plans to establish its international presence, with a focus on the Korean medical market. By collaborating with SCL Group, H2U will introduce a SaaS-based digital health check platform and a post-check health management program in South Korean medical examination centers. The company also aims to participate in prestigious international medical events, such as Medica Germany, CES, and the J.P. Morgan Healthcare Conference in the USA, as part of their strategy to become Asia’s leading digital health unicorn.
As H2U continues to innovate and expand its reach, the company is expected to undergo an IPO by the end of the year to further support its technological research and development efforts. With a strong focus on precision nutrition, preventive medicine, and holistic health solutions, H2U is well-positioned to lead the digital health revolution in Asia and beyond.
Image source: H2U CORPORATION – Series B Fundraising
(Source: PRNewswire)
Source link